The START Center for Cancer Research ("START"), the world's largest community-based network of clinical trial sites ...

April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...

OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant's dosing following the ...

Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety ...

The planned Phase 2 trial will evaluate the efficacy, safety and tolerability of Lucid-MS in people with MS. Quantum ...

ROCKVILLE, Md., April 9, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant's dosing following the clearance of the Investigational ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that the first cohort of healthy volunteers has been ...

Add Yahoo as a preferred source to see more of our stories on Google. In 1747, James Lind conducted one of the earliest comparative trials, testing oranges and lemons to treat scurvy in sailors. In ...

Her career has taken her from treating patients to developing new medicines for biopharma, and now Nancy L. Lewis, MD, MBS, ...

Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet ...

Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in ...

The controlled, randomised global Phase III trial will enrol 830 patients.